February 2022 - The Epidemiology Monitor by The Epidemiology Monitor

Epidemiologists Discuss The Meaning Of Living With COVID-19 Fewer Right Answers Apply Universally Now Much of the media coverage in recent days has focused on when the end of the COVID pandemic will happen and what this new state of affairs will entail, that is, the “new normal”. Pinpointing the end of the pandemic involves making predictions about the epidemiology of SARS-CoV-2, and few epidemiologists or other experts claim to be certain about this future evolution. Nevertheless, there is no shortage of views of what the new landscape will look like.

are approaching the next phase of the pandemic, regardless of what they believe that next phase will bring (NYTimes). In short, what are epidemiologists thinking about when they think about living with the “new normal”?

-3-

New Haiku Contest -6Notes On People

Multiple Considerations What is striking from the interviews is the number of different considerations that emerged in what turn out to be risk/benefit decisions being made by

Reporters recently contacted over a dozen epidemiologists to ask how they

- Living con't on page 2

Advice To “Follow The Science” Described As Misleading Approach To COVID Response Tradeoffs In Risk/Benefit Decisions Also Require Consideration Of Values Epidemiologists, scientists, and policymakers committed to evidencebased decision making can often be heard or quoted saying “follow the science” in making public health policy decisions. The implication is that the facts will speak for themselves and that an objectively correct and defensible decision can be arrived at by relying on February 2022

In This Issue

scientific data. As the COVID-19 pandemic has evolved and public health decisions have been challenged by different segments of society, the appropriateness of urging a "just - Misleading cont'd on page 5 •

Volume Forty Three •

Number Two

-8Event Calendar -9Quote of the Month -10Marketplace This Month

-Living cont'd from page 1 The Epidemiology Monitor ISSN (0744-0898) is published monthly by Roger Bernier, Ph.D., MPH at 7033 Hanford Dr,, Aiken, SC, 29803, USA. Editorial Contributors Roger Bernier, PhD, MPH Editor and Publisher

Operations Linda Bernier, PhD, MS Operations Manager

Advertising Sales Linda Bernier, PhD, MS Director of Advertising 770.533.3436 linda@epimonitor.net Advertising Rates All ads listed below also include a banner ad on our website and in our EpiGram emails. Full Page $1,195 7.5”w x 10” h Half Page $895 7.5”w x 4.75” h Website Ad $495 / mo. Includes a banner ad in our EpiGram emails Multi-month discounts available upon request.

epidemiologists and others. Some of these considerations have to do with realities about the virus, some with what human activities are being contemplated, and others with what control measures are possible or available. Some of the factors being considered in the decision making are: Realities:  The impossibility of SARS-CoV2 virus eradication  The ongoing need to reduce personal risk  The ongoing need to reduce community risk, especially for more vulnerable persons  The level of community risk at any particular point in time  The wide variety of existing control measures to choose from  The approaches we use in making risk/benefit decisions for other viruses which circulate  The need to accept the reality of a new level of risk in our lives  The varying circumstances of our individual lives  Current capacity of the health care system locally  Vaccination status of children Control measures:  Vaccinations  The use of well-fitting masks  Testing for virus at home  Quality of building ventilation Impacted Activities    

Dining indoors Traveling by air Socializing with elderly persons Attending movies, theater, and concert events indoors



Visiting other persons in their homes More Individual Decisions

Whether due to fatigue with the pandemic or a better appreciation of the negative consequences of control measures, it appears that the risk/benefit decisions to be made during the “new normal” will be more individually tailored than earlier in the pandemic. In short, there will be no right decisions that apply universally in this phase of the pandemic as many thought there were in the earlier phase of the pandemic (e.g., lockdowns, school closures, ban on mass events, etc.) Deaths Still Above Expected Level This change in thinking is taking place even when deaths are still occurring in excess of the expected threshold. The latest excess deaths data from CDC indicate that deaths in late January were still 10.5% above the expected number per week. And CDC and the White House are not calling for a relaxation of control measures in the way that some states are doing for example with masking requirements. How Pandemics End As pointed out in a recent Washington Post commentary, “the end of respiratory pandemics has never been clear cut...the key to ending the pandemic, therefore, isn’t biological. It is social…At the end of the day, it is not the virus that makes the timeline--it is us. The pandemic will be over when we say it’s over.” ■

On The Light Side Bringing Wit and Wisdom To Epidemiology--AGAIN New Haiku Contest To Focus On Impact Of The Pandemic On Epidemiology And Epidemiologists $1,000 In Cash Prizes Webster’s Dictionary defines haiku as “an unrhymed Japanese poetic form that consists of 17 syllables arranged in three lines containing five, seven, and five syllables, respectively. A haiku expresses much and suggests more in the fewest possible words.” The Epidemiology Monitor first sponsored a haiku contest in 2016. The purpose of that contest was to elicit haikus which best captured the methods or purposes of epidemiology. More than 200 readers selected their favorite haikus (see reprint this month of the August 2016 newsletter with the winning haikus). New Contest This month we are launching a second haiku contest to capture the changes and challenges brought to epidemiology and/or to epidemiologists as a result of the COVID-19 pandemic. The field and the profession have never been such a prominent part of national and international conversations. Our contest seeks to capture the insights which epidemiologists have garnered about the positive and the negative as a result of this unprecedented attention. This is a chance to share the insights from your lessons learned in the pandemic.

Cash Prizes The winner for the best entry will receive a $500 cash prize, and second and their place winners will receive $300 and $200 respectively. All entries become the exclusive property of the newsletter. The deadline for submission is April 30, 2022. Send your entries to editor@epimonitor.net

“A haiku expresses much and suggests more in the fewest possible words.”

There is no limit to the number of entries allowed. In the event that two haikus are very similar, the earliest one submitted will receive priority consideration. All decisions made by our panel of judges will be final. Be the first to submit at editor@epimonitor.net ■

Join us on our Facebook page at:

“This is a chance to share the insights from your lessons learned in the pandemic."

https://bit.ly/2U29gUA

Abridged Reprint August 2016 Haiku Contest Winners Francois Theriault, a second year PhD student in the School of Epidemiology, Public Health, and Preventive Medicine at the University of Ottawa is the winner of our popular haiku contest and a $300 cash prize. He submitted a single haiku and received more than double the number of first place ranks compared to the nearest competitors. His winning haiku by this wide margin is: Silent fall of tears Wasted grant and squandered youth P of point o six When asked to comment on his inspiration for the winning haiku, Theriault told the Monitor “I am often frustrated with the importance attributed to arbitrary p-value cut-offs. This frustration was the main inspiration for my haiku. I tried to capture the absurdity and angst of the precise, deflating moment when researchers realize that their findings fall just short of an arbitrary cut-off for statistical significance, and that few people will consequently be interested in their results.” 2nd Place Winner: Egg salad, stuffed ham Hot sun, cool shade, eat and play Outbreak tomorrow 3rd Place Winner: Disease detective Searching for a cause and cure Alas, no funding Other haikus which garnered the most votes were: With Snow in pursuit Of pump handle causation A science is born

Preventable deaths Epi curves will save the world If funding follows

Confounded no more Perhaps association Reveals causation

Genies grant wishes But poor epi researchers Wish for grants instead

“Association’ Be sure not to confuse this Word with “causation”

Disease shed data Epidemiology Spreads understanding

Disease within few Provides us with the insight To prevent in more ■

-Misleading cont'd from page 1 “follow the science” approach is being found wanting. Shortcomings In a clear exposition of the shortcomings of this approach, David Leonhardt writing in the New York Times suggests the public (and presumably the scientists too) misunderstand science by imagining it “… almost as a god—Science—which can solve our dilemmas if only we listened.” Tradeoffs In fact, public health requires values trade-offs in making risk benefit decisions. Such decisions require facts but also weighing of the risks and benefits of different courses of action, and the right choice is not often clearcut. Leonhardt quotes a Georgetown University political scientist who tweeted “Don’t trust substantive experts to make policy decisions that balance competing values or stakeholder interests.” If you should not trust experts, who do you trust and how do you decide?

conversation." And as she told the EpiMonitor, it should be within the public health community itself and between public health and the general public. Leonhardt points out “The answer will not spring forth from Science. It really is a conversation.” Ultimate Goal In a podcast interview on Just Serious with Josh Barro, Leonhardt argues further for having a clear goal when facing public health dilemmas. He believes we should not be solving these problems by making the impact on COVID the ultimate success indicator. We should be solving dilemmas by seeking to identify what is best for the “total well-being of society”.

“Don’t trust substantive experts to make policy decisions that balance competing values or stakeholder interests.”

By that measure, the right answer might be different for the period of time before COVID vaccines were available than what it might be now. We have a better appreciation for the negative impacts on school learning, drug abuse, murders, and suicides than we did at the outset. Public Input

The right approach cannot be geared towards finding the ultimate expert but rather in relying more on aggretating Best Approach public judgments and opinions. According to Leonhardt, in a democracy, Given that there is not one correct answer to public health dilemmas such the collective wisdom that can be garnerd from the public has to be an important as mask mandates, school closures during outbreaks and other topics, and input in making values trade-off given that decisions should change as decisions. The mechanisms to convene and host these crucial public realities change, what is the best conversations have not been put in place approach to policymaking that involves both the consideration of facts but could become a higher priority in post-pandemic public health when the and values? lessons learned from the pandemic become more widely known and One answer comes from Janet accepted. Baseman, an epidemiologist at the ■ University of Washington who states "we need to be having this

“The answer will not spring forth from Science. It really is a conversation.”

Notes on People Do you have news about yourself, a colleague, or a student? Please help The Epidemiology Monitor keep the community informed by sending relevant news to us at this address for inclusion in our next issue. people@epimonitor.net

Died: Jeremiah Stamler, age 102, at his home in Sag Harbor Long Island New York. The American Heart Association called Dr Stamler, “the father of preventive cardiology.” His obituary in the NY Times quotes many colleagues, including Lawrence Appel from Johns Hopkins saying “Many colleagues, including myself, believe that he is largely responsible for the remarkable decline in coronary heart disease and stroke that occurred in the US over the past few decades.” Another Donald Lloyd-Jones at Northwestern states “He was part of a generation of scientists who put the traditional risk factors for heart disease on the map.” His obituaries contain multiple inspiring and interesting facts at https://nyti.ms/3gNCUKW https://bit.ly/34KmnoB Resigned: Dawn Comstock, on February 7, 2022 as the Jefferson County Colorado Public Health Director. According to news reports, she transitioned about one year ago from being an epidemiology professor at the University of Colorado Anschutz and had felt motivated use her epidemiologic skills to help fight the COVID pandemic. The resignation took place after a special board of health meeting and the exact reasons for the resignation were not made public at the time of publication. According to Colorado Public Radio, Comstock’s predecessor Dr Mark Johnson said he’s sorry for Comstock and Jefferson County and wishes Comstock the best. He also acknowledged how the pandemic has made the job more difficult. “Public health has never been more stressed than it has been over the past two and half years, and much of this stress has fallen directly and unfairly on local public health department directors,” Johnson said. Elected: Sten Vermund, as Vice President/President Elect of the Connecticut Academy of Science and Engineering. Dr Vermund is an infectious disease epidemiologist and currently Dean of the Yale School of Public Health until later this year. The Academy’s President said “Dean Vermund’s leadership will ensure the Academy continues well into the future the celebration of our state’s rich and diverse science, technology, engineering, mathematics and medical talent, and our commitment to informing about and promoting science and engineering for the benefit of the state.” Vermund said the Academy is “a rare resource, almost unique across US states and territories.”

Appointed: David Hayman, to the Percival Carmine chair in epidemiology and public health at New Zealand’s Massey University. According to media accounts, the chair has been newly funded by Massey alumni with $3.5 million for the next ten years. Dr Hayman is a world expert in infectious disease ecology and has a particular expertise in emerging bat infections. He is involved in a research project exploring what factors allow pathogens to jump from animals to humans.

Profiled: Quynh Nguyen and Thu Nguyen, as twin sisters working side by side in the Department of Epidemiology and Biostatistics at the University of Maryland. According to Maryland Today, “…they’ve been on the same path almost their entire lives, earning their undergraduate and master’s degrees from the same schools in the same major.” According to Quynh, “sometimes (siblings) feel like ‘I need to be as good or better than my sibling. Our relationship’s more collaborative’.” The fraternal pair do not look more alike than other siblings do, however, their research is similar though not identical. Winner: Emily Smith, of a 2021 Distinguished Alumni award from Wayland Baptist University. She is a research scholar at the Duke Global Health Institute where her research interests include children’s global surgery, strengthening health systems in low-income countries, health economics and global health policy. The University’s public relations director stated “We have watched Dr. Smith’s career blossom and have been so proud of the impact she has had both on academia and on global public health. When she became a voice of research and reason during the COVID pandemic, we were even more proud to see her temper her experience with her faith and grace in the public forum. She is an excellent choice for a distinguished alumnus and we are beyond honored to recognize her in this way.”

Profiled: Emmanuel Opada, Victoria County Texas Public Health’s new epidemiologist as of November 2021. Prior to taking this position Opada started his career in public health in Nigeria and pursued his master’s degree in epidemiology in the U.S. at St. Louis University. Opada told local media “This is a great opportunity to pursue my passion,” noting that he feels it’s his calling in public health to provide analytic support to health professionals.

8 Near Term Epidemiology Event Calendar Every December The Epidemiology Monitor dedicates that issue to a calendar of events for the upcoming year. However that often means we don't have full information for events later in the upcoming year. Thus an online copy exists on our website that is updated regularly. To view the full year please go to: http://www.epimonitor.net/Events The events that we are aware of for the next two months follow below.

March 2022 March 1-4 http://bit.ly/2P1uouz Conference / Epi Lifestyles 2022 Scientific Sessions / American Heart Association / Chicago, IL - Hybrid March 6-9 https://bit.ly/3DPsovK Conference / 11th International Conference on Emerging Infectious Diseases / CDC / Atlanta, GA March 7-11 http://bit.ly/33XqJSJ Short Course / Intensive Course in Applied Epidemiology / University of Aberdeen / Aberdeen, Scotland March 10-11 http://bit.ly/353kNZY Conference / 93rd Annual Meeting - American Epidemiological Society / AES / Atlanta, GA March 13-15 http://bit.ly/34XZw3L Conference / 46th Annual Conference - American Society of Preventive Oncology / ASPO / Tucson, AZ March 14-18 https://bit.ly/320OvlT Short Course / Advanced Clinical Trials / Erasmus MC / Rotterdam, The Netherlands March 21-24 https://bit.ly/3s7H5rW Conference / Public Health & Wastewater Disease Surveillance Summit / Water Environment Federation / Cincinnati, OH March 23-25 https://svepm2022.org/ Conference / Annual Meeting - Society for Veterinary Epidemiology / SEVPM / Belfast, Ireland March 30 - April 1 https://bit.ly/31YqOdE Conference / 8th International Conference on Neurology & Epidemiology / International Society of Neurology & Epidemiology / VIRTUAL

April 2022 April 2-5 http://bit.ly/2DZtMPU Conference / 56th Annual Meeting of the European Diabetes Epidemiology Group (EDEG ) / EDEG / Hersonissos, Crete, Greece April 3-7 https://bit.ly/3oLZ2Kz Conference / NACCHO (National Association of County and City Health Offices) Preparedness Summit 2022 / Multiple / Atlanta, GA April 4-5 https://bit.ly/3Hf8Vr9 Conference / 2022 Health Datapalooza & Health Policy Conference / Academy Health / Arlington, VA

Near Term Epidemiology Event Calendar, con't April 6-9 https://bit.ly/3e7B725 Conference / 2022 Annual Conference - Population Association of America / Population Association of America / Atlanta, GA April 8-13 https://bit.ly/3oLgYVu Conference / 2022 Annual Meeting - American Association for Cancer Research / AACR / New Orleans, LA April 10-12 https://bit.ly/2VRFqoZ Conference / ISPE 2022 Mid-Year Meeting / International Society for Pharmacoepidemiology / Orlando, FL April 11-14 https://bit.ly/3GOXS7f Short Course / Psychiatric Epidemiology / Erasmus MC / Rotterdam, The Netherlands April 12-14 https://bit.ly/3p3hMCw Conference / SHEA (Society for Healthcare Epidemiology of America) Spring 2022 / SHEA / Colorado Springs, CO - Hybrid April 19-21 https://bit.ly/2C4g1PE Short Course / Quality of Life Measurement / Erasmus MCl / Rotterdam, The Netherlands April 19-21 https://bit.ly/3DSAjrW Conference / Tribal Public Health Conference / Multiple / Hybrid - Location TBA April 23-26 https://bit.ly/2VRaqVX Conference / 30th European Congress of Clinical Microbiology & Infectious Diseases / ESCMID / Lisbon, Portugal April 24-26 https://bit.ly/3rX33gV Conference / Health Effects International 2022 Conference / HEI / Washington, DC April TBA https://bit.ly/3IO7yAC Short Course / Child Psychiatric Epidemiology / Erasmus MC / Rotterdam, The Netherlands

Quotes of the Month On Quality Data “Without it, scientists given the job of informing the public about vital public health issues are like unarmed soldiers in a war zone.” Article by South African researchers H Combrink, B Smart, S Hazelhurst, and V Marivate published at The Conversation, January 26, 2022 On the Value of Population Level Thinking “If you are sick, even with severe COVID, you want someone with a doctor’s viewpoint caring for you. America, however, is not a patient. And we’d all be better off, as a society and as individuals, if those in control of our country stopped thinking of it that way.” Article by Aaron Carroll published in the NY Times, January 14, 2022

Epidemiology's Summer Institute at Columbia University Early discounts available until April 1, 2022 Registration open through May 1, 2022

For a Full List of Courses Offered in EPISUMMER@COLUMBIA 2022 Visit: cuepisummer.org

Department Chair Tenured Professor of Epidemiology Bridging to a healthier world. Bridging to a brighter future. The University of Pittsburgh Graduate School of Public Health is accepting applications for a Department Chair and Tenured Professor of Epidemiology. Just like our beloved city of 446 bridges, Pitt Public Health is a school like no other. Spanning across seven academic departments, nearly 650 students and 500 combined faculty and staff, join a diverse and vibrant community of researchers, educators, students, collaborators, and leaders. The Department has 43 faculty, 121 students and 112 staff and an international reputation for leadership in areas such as cardiovascular epidemiology, reproductive health, cancer control and prevention, and the epidemiology of aging. The new Chair will contribute directly to a st new era in epidemiology, bringing dynamic vision and leadership on the importance of population health in the 21 century to build on a strong foundation of research, teaching, and service. It is expected that the incoming Chair will have the skills to foster broad collaboration across the health sciences schools and across the research continuum from bench to clinic to population and community health and that the Chair will support the department in leveraging new methodological techniques such as multi-omics, large cohort and health system data, and causal inference frameworks. Importantly, this individual will be part of a cohort of new leaders at Pitt Public Health embracing the School’s four priorities in research and education that include: precision public health; climate and health; diversity, equity and inclusion; and inspiring the youngest students among us through the School’s Bachelor of Science in Public Health program. The Chair is expected to play a prominent role in the local, regional, national and global biomedical and population-based research and education and community practice. Additional information about this position (requisition #22000201) is available via the application portal using at www.join.pitt.edu . Review of applications will begin immediately and continue until the position is filled. Candidates should submit a letter of interest that addresses motivation to apply and summarizes professional accomplishments, a 1-page Diversity Equity and Inclusion effort and vision statement, curriculum vitae and contact information for three referees. Candidates from historically underrepresented communities are encouraged to apply.

The University of Pittsburgh is an Affirmative Action/Equal Opportunity Employer and values equality of opportunity, human dignity and diversity, EOE, including disability/vets.

Senior Biostatistician The Cystic Fibrosis Foundation clinical trial coordinating center and research organization at Seattle Children's Hospital Research Institute has an opening for an experienced Biostatistician to join a devoted and growing team of local and national investigators to advance therapies and find a cure for children and adults living with cystic fibrosis. Our group is a cohesive mix of Biostatistical faculty and staff, statistical programmers, data managers, clinical operations staff, and physicians/scientists. Responsibilities ♦

Serve as lead statistician on clinical trials or observational studies and participate in various phases of clinical research including pre-study planning, protocol and statistical analysis plan development

♦ Work effectively and collaboratively on multidisciplinary teams ♦ Oversee work of other statisticians, statistical programmers and data managers ♦

Implement statistical methods for analysis of data from clinical trials, observational studies, registries and data banks

♦

Conduct and oversee interim and final study reporting including data safety monitoring board reports, analyses, and manuscript preparation

♦

Interface and consult with principal investigators regarding hypothesis generation, study design, protocol development and implementation, analysis and interpretation of results

♦ Contribute to productivity and process improvements Desired Experience

♦ Clinical trial design and execution, epidemiologic analyses or comparative effectiveness research ♦ Demonstrated project management skills in particular as it pertains to analytic projects and complex data pipelines ♦ Demonstrated knowledge in statistical methods and concepts ♦ Strong statistical programming skills in SAS, R or similar statistical package ♦ Working in multidisciplinary teams ♦ Co-authoring publications ♦ Strong verbal and written communication skills Those with industry and/or academic backgrounds are welcome to apply. The successful candidate will have the opportunity to design and oversee complex randomized, CER, observational and registry-style studies. The Seattle Children’s Research Institute is an innovative leader in pediatric health and wellness through quality, clinical care, relentless spirit of inquiry, and compassion for children and their families.

Apply here: https://bit.ly/34Hpdua

DEPARTMENT OF EPIDEMIOLOGY AND PUBLIC HEALTH UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE DIVISION OF GERONTOLOGY SEARCH REOPENED

LEADERSHIP OPPORTUNITY IN AGING & PUBLIC HEALTH SCIENCES Division Director The Department of Epidemiology and Public Health of the University of Maryland School of Medicine is seeking a division director at the associate or full professor rank for an exciting opportunity to expand and accelerate the growth of the Division of Gerontology. A generous and competitive start-up package will be provided to support the division director’s research initiatives and growth of the division. The successful candidate for the division head position will be a national leader with commitment to conducting and fostering interdisciplinary research in the epidemiology of aging and gerontology, will have a record of extramural research funding, and leadership and management capabilities. The division director is expected to develop and enhance collaborative research within the division, department, and medical system, and actively teach and participate in the department’s training programs for graduate students and post-doctoral fellows. Opportunities to teach medical students and students in other professional schools on our health services campus also are possible. The division’s seven faculty members have ongoing multidisciplinary research and collaborations across campus, focused on strategies to prevent and improve outcomes from disabling conditions among older persons. Gerontology division faculty collaborate with others throughout the University of Maryland Baltimore campus, which includes six professional schools (medicine, nursing, pharmacy, dentistry, social work, and law), other University of Maryland campuses, as well as those in other academic and industry settings. The division also is the administrative home for the campus-wide Center for Research on Aging, the Claude D. Pepper Older Americans Independence Center – funded since 1994, the Gerontology Doctoral Program, and the federally funded Research Training in the Epidemiology of Aging (T32). The department, which is ranked first in NIH funding for like-departments in public schools of medicine, comprises 45 full-time faculty members, has strong research programs in cancer epidemiology, genomic and infectious disease epidemiology, translational toxicology, biostatistics, preventive medicine, and health disparities and population health. The department is also the home for doctoral degree programs in Epidemiology and Human Genetics, and in Gerontology, as well as master’s programs in epidemiology, clinical research, and public health. Qualifications: Ph.D. and/or M.D. with significant experience collaborating in an interdisciplinary research setting, background in epidemiology and/or gerontology, and an established record of extramural research funding are required. For confidential inquiries, please contact Dr. Jack Guralnik at jguralnik@som.umaryland.edu or Dr. Ann Gruber-Baldini at abaldin@som.umaryland.edu. TO APPLY: Please submit applications online at: https://umb.taleo.net/careersection/jobdetail.ftl?job=170001XK&lang=en#.WjliERVAqss.email Applications should include a cover letter indicating research interests, CV, and names of 3 references. Reference position # 03-307-143. The University of Maryland, Baltimore is an Equal Opportunity, Affirmative Action Employer. Minorities, women, veterans, and individuals with disabilities are encouraged to apply.

Principal Biostatistician The Cystic Fibrosis Foundation clinical trial coordinating center and research organization at Seattle Children’s Hospital Research Institute has an opening for an experienced Biostatistician to join a devoted and growing team of local and national investigators to advance therapies and find a cure for children and adults living with cystic fibrosis. Our group is a cohesive mix of Biostatistical faculty and staff, statistical programmers, data managers, clinical operations staff, and physicians/scientists. Responsibilities ♦ Provide statistical and scientific input and consultation for major scientific projects ♦ Perform highly complex and technical statistical analyses and design. ♦ Initiate and write manuscripts and grant analysis sections. ♦ Coordinate and direct data-oriented projects. Participate as Senior Statistician on clinical studies and lead study design and protocol development; Provide ♦ senior statistical oversight throughout the course of the study; and preparation of methods sections for grant submissions and manuscripts. ♦

Conduct methodological research which includes researching and adapting new methods for complex analysis or study design.

♦

Provide mentorship and training to others in the research community and biostatistical group including junior statisticians/programmers and students/research assistants.

♦ Contribute to productivity and process improvements Desired Experience ♦ Consulting experience in statistical design or clinical trials. ♦ Clinical trial design and execution, epidemiologic analyses or comparative effectiveness research ♦ Experience with advanced quantitative methods ♦ Demonstrated project management skills in particular as it pertains to analytic projects and complex data pipelines ♦ Demonstrated knowledge in statistical methods and concepts ♦ Strong statistical programming skills in SAS, R or similar statistical package ♦ Working in multidisciplinary teams ♦ Authoring publications ♦ Strong verbal and written communication skills Those with industry and/or academic backgrounds are welcome to apply. The successful candidate will have the opportunity to design and oversee complex randomized, CER, observational and registry-style studies. The Seattle Children’s Research Institute is an innovative leader in pediatric health and wellness through quality, clinical care, relentless spirit of inquiry, and compassion for children and their families. Apply here: https://bit.ly/34IUe0L

Your Ad Should Be Here Do you have a job, course, conference, book or other resource of interest to the epidemiology community? Advertise with The Epidemiology Monitor and reach 35,000 epidemiologists, biostatisticians, and public health professionals monthly.

Advertising opportunities exist in this digital publication, on our website and Facebook page, and in our Epi-Gram emails.

For more information please contact:

Linda Bernier, Director of Advertising / 770.533.3436 / linda@epimonitor.net

The Epidemiology Monitor in a Digital Version is available FREE to subscribers The Epidemiology Monitor is available exclusively online in the same familiar print format subscribers were accustomed to, and they can read through the publication on their electronic devices in the same manner they did with the print version. In addition, you can download and save copies of The Epidemiology Monitor for easy future access. This digital publication format provides: ► Easier access to information that is more timely ► Publication alerts via email ► Embedded hot links in articles ► Full color advertising ► Wider circulation for advertisers

SUBSCRIBE FOR FREE TODAY AT: http://epimonitor.net/Subscribe.htm